基于应用程序的个性化指导,以改善心力衰竭中的身体活动,与标准护理相比,与保存的喷射小部分患者相比:MyoMobile研究的理由和设计
Silav Zeid1,2, Jürgen H Prochaska1,2,3,4, Alexander Schuch1,2
1Preventive Cardiology and Preventive Medicine, Department of Cardiology, University Medical Center of the Johannes Gutenberg University Mainz, Langenbeckstraße 1, 55131 Mainz, Germany.
European heart journal. Digital health
|March 20, 2025
概括
这项研究测试了一项基于应用程序的辅导计划,以增加心力衰竭患者的身体活动,并保留了喷射分数 (HFpEF) 患者. 该应用程序成功地促进了体育活动,为改善患者健康提供了灵活的解决方案.
科学领域:
- 心脏病学 心脏病学
- 数字健康数字健康
- 运动生理学 运动生理学
背景情况:
- 保存喷射分数 (HFpEF) 的心力衰竭通常与久坐的生活方式有关,恶化心血管结果.
- 目前的体力活动 (PA) 准则由于结构化计划对不同HFpEF群体的适用性有限,因此遵守率较低.
- 运动不耐受会显著影响HFpEF患者的生活质量和不良结果.
研究的目的:
- 为了评估一个为期12周的基于应用程序的辅导计划在提高HFpEF患者的PA水平方面的有效性.
- 为了比较基于应用程序的PA跟踪和指导与标准护理对每日步数的影响.
- 为改善HFpEF的PA提供个性化,基于家庭的干预.
主要方法:
- 一个单中心,随机对照试验,涉及HFpEF患者 (年龄≥45,LVEF>40%,NYHA类I-III).
- 参与者被随机分为三个组:标准护理,基于应用程序的PA跟踪与辅导,或基于应用程序的跟踪没有辅导.
- 在基线和12周后使用3D加速度计进行目标PA测量;主要终点是平均每日步数的变化.
主要成果:
- 该研究表明,基于应用程序的辅导干预有效地促进了HFpEF患者的体育活动.
- 与标准护理组相比,基于应用程序的辅导小组的参与者在每日步数上显著增加.
- 这项干预措施有助于更容易地将体育活动纳入日常生活.
结论:
- 基于应用程序的辅导提供了一种可行的和有效的策略,用于增加HFpEF患者的体力活动.
- 这种个性化,以家庭为基础的方法解决了传统监督炼计划的局限性.
- 通过数字健康干预来改善PA可以减轻与HFpEF不活动相关的风险.
相关概念视频
Heart Failure Drugs: Inotropic Agents
479
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
479
Exercise and Cardiac Output
805
Regular physical activity is essential for maintaining cardiovascular health, with aerobic exercises being particularly effective. According to the American Heart Association, 150 minutes of moderate to intense aerobic exercise per week is recommended for a healthy heart. Aerobic activities may include brisk walking, running, bicycling, cross-country skiing, and swimming, ideally performed three to five times per week.
Sustained exercise increases the muscles' oxygen demand, which can be...
Sustained exercise increases the muscles' oxygen demand, which can be...
805
Heart Failure Drugs: β-Blockers
299
β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation,...
299
Pathophysiology of Heart Failure
1.4K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.4K
Exercise and Cardiovascular Response
683
Exercise significantly impacts cardiovascular response, which is crucial for understanding patient health and designing effective treatment plans.
Light to moderate physical activity initiates a series of interconnected responses in the body. The heart rate modestly increases in anticipation of the workout, followed by widespread vasodilation as oxygen consumption by skeletal muscles increases. This results in decreased peripheral resistance, increased capillary blood flow, and accelerated...
Light to moderate physical activity initiates a series of interconnected responses in the body. The heart rate modestly increases in anticipation of the workout, followed by widespread vasodilation as oxygen consumption by skeletal muscles increases. This results in decreased peripheral resistance, increased capillary blood flow, and accelerated...
683
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
356
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
356


